1,594 results match your criteria Non-Hodgkin Lymphoma Thoracic

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma.

Theranostics 2021 4;11(10):4699-4709. Epub 2021 Mar 4.

Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.

The onset of cytokine release syndrome (CRS) and persistence of anti-CD19 chimeric antigen receptor T (CAR-T) cells after infusion correlate with clinical responsiveness. However, there are no known baseline biomarkers that can predict the prognosis of patients with B-lineage non-Hodgkin lymphoma (B-NHL). The aim of this study was to identify blood cell populations associated with beneficial outcomes in B-NHL patients administered CAR-T cell immunotherapies. Read More

View Article and Full-Text PDF

Case series of trans-thoracic nodule aspirate performed by interventional pulmonologists.

Respir Med Case Rep 2021 2;32:101362. Epub 2021 Feb 2.

Division of Pulmonary, Allergy & Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Percutaneous interventional tissue sampling of pulmonary masses and lymphadenopathy is a means for diagnosis of thoracic malignancy. The user base that can perform this skill with ultrasound guidance is expanding. A retrospective cohort of fine needle aspiration and percutaneous core biopsies was identified to evaluate their safety and efficacy. Read More

View Article and Full-Text PDF
February 2021

Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.

Surg Case Rep 2021 Feb 5;7(1):41. Epub 2021 Feb 5.

Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima, 890-8520, Japan.

Background: Anaplastic large cell lymphoma (ALCL) is a CD30-positive T-cell lymphoma, which is a rare type of non-Hodgkin lymphoma. ALCL rarely presents in the gastrointestinal tract, and the esophageal involvement in of ALCL is extremely rare.

Case Presentation: An 11-year-old boy who complained of abdominal pain and cough was diagnosed with ALK-positive ALCL on the basis of systemic lymphadenopathy findings and immunohistochemistry results of pleural effusion. Read More

View Article and Full-Text PDF
February 2021

Primary Hepatic Lymphoma After Lung Transplantation: A Report of 2 Cases.

Transplant Proc 2021 Mar 30;53(2):692-695. Epub 2021 Jan 30.

Digestive and Endocrine Surgery, Nouvel Hopital Civil, University of Strasbourg, Strasbourg, France; IHU Strasbourg, Institute of Image-Guided Surgery, Strasbourg, France; IRCAD, Research Institute Against Digestive Cancer, Strasbourg, France. Electronic address:

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in the posttransplant setting. Treatment is based on chemotherapy; surgery is still debated and should be performed in very select cases.

Methods: We observed 2 patients out of 300 who underwent lung transplantation in the Nouvel Hopital Civil between 2013 and 2019 with primary hepatic lymphoma. Read More

View Article and Full-Text PDF

Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Cancers (Basel) 2021 Jan 22;13(3). Epub 2021 Jan 22.

Pathology Unit, Azienda Ospedaliera S. Maria di Terni, University of Perugia, 05100 Terni, Italy.

Primary pulmonary B-cell lymphomas (PP-BCLs) comprise a group of extranodal non-Hodgkin lymphomas of B-cell origin, which primarily affect the lung without evidence of extrapulmonary disease at the time of diagnosis and up to 3 months afterwards. Primary lymphoid proliferations of the lung are most often of B-cell lineage, and include three major entities with different clinical, morphological, and molecular features: primary pulmonary marginal zone lymphoma of mucosa-associated lymphoid tissue (PP-MZL, or MALT lymphoma), primary pulmonary diffuse large B cell lymphoma (PP-DLBCL), and lymphomatoid granulomatosis (LYG). Less common entities include primary effusion B-cell lymphoma (PEL) and intravascular large B cell lymphoma (IVLBCL). Read More

View Article and Full-Text PDF
January 2021

Complete heart block as a herald sign for cardiac lymphoma.

BMJ Case Rep 2021 Jan 11;14(1). Epub 2021 Jan 11.

Cardiology, Royal Gwent Hospital, Newport, South Wales, UK.

A previously well 48-year-old man presented with presyncope and was found to be in complete heart block. Blood tests, echocardiography and coronary angiography were reported as normal, and a dual chamber permanent pacemaker was inserted. Six months later he re-presented with breathlessness. Read More

View Article and Full-Text PDF
January 2021

Efficacy and safety of chimeric antigen receptor T cell immunotherapy in B-cell non-Hodgkin lymphoma: a systematic review and meta-analysis.

Immunotherapy 2021 Mar 7;13(4):345-357. Epub 2021 Jan 7.

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

The aim was to evaluate the efficacy and safety of chimeric antigen receptor T (CAR-T) cell in B-cell non-Hodgkin lymphoma (B-NHL). A meta-analysis was conducted using eligible clinical trials, which were obtained from electronic medical literature databases. A total of 24 clinical trials with 590 patients were included. Read More

View Article and Full-Text PDF

Sintilimab: A Promising Anti-Tumor PD-1 Antibody.

Front Oncol 2020 26;10:594558. Epub 2020 Nov 26.

Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

Sintilimab (Tyvyt) is a monoclonal antibody against programmed cell death protein 1 (PD-1). It could block the interaction between PD-1 and its ligands and help the anti-tumor effect of T-cells to recover. Sintilimab is developed by Innovent Biologics and Eli Lilly and Company and has been approved to treat relapsed or refractory classical Hodgkin lymphoma in patients who have undergone two or more lines of systemic chemotherapy by the National Medical Products Administration of China. Read More

View Article and Full-Text PDF
November 2020

Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.

Biochem Biophys Res Commun 2021 01 13;534:773-779. Epub 2020 Nov 13.

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

Mantle Cell Lymphoma (MCL) is a non-Hodgkin lymphoma with a median survival rate of five years. Standard treatment with high-dose chemotherapy plus rituximab (anti-CD20 antibody) has extended overall survival although, the disease remains incurable. Histone deacetylases (HDAC) are a family of enzymes that regulate multiple proteins and cellular pathways through post-translational modification. Read More

View Article and Full-Text PDF
January 2021

Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma.

Front Oncol 2020 7;10:500153. Epub 2020 Oct 7.

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Background: Inadequate accuracy of ultrasound-guided core needle biopsy (US-CNB) urges further improvement for the diagnosis and management of lymphoma to meet with the practitioners' increased reliance on this mini-invasive approach.

Methods: Data related to US-CNB of the deep-sited dominant lesions suspicious of lymphoma detected by computer tomography or positron-emission tomography/computer tomography for eligibility assessment of three prospective clinical trials were collected in advance. A retrospective analysis of the prospective data collection was performed, in which Viable-targeting US-CNB that Color Doppler flow imaging (CDFI) and/or contrast enhanced ultrasound (CEUS) were employed to select viable area for biopsy target compared with Routine US-CNB that routine procedure of evaluation and guidance using gray-scale ultrasound with CDFI in terms of the yield of clinically actionable diagnosis and safety, and determinants for the successful US-CNB that established an actionable diagnosis were explored. Read More

View Article and Full-Text PDF
October 2020

18F-FDG PET/CT of Double Expressor High-Grade B-Cell Lymphoma in an Isolated Chest Wall Mass.

Punit Sharma

Clin Nucl Med 2021 Jan;46(1):76-77

From the Department of Nuclear Medicine and PET/CT, Apollo Gleneagles Hospitals, Kolkata, India.

F-FDG PET/CT is now an integral part of management of high-grade B-cell lymphoma. It is used for staging, response evaluation, restaging, and surveillance. Although high-grade B-cell lymphoma most commonly presents with involvement of the lymph nodes, spleen, liver, and bone marrow, chest wall involvement is very rare. Read More

View Article and Full-Text PDF
January 2021

Cervical radiculopathy as first presentation of CD3-positive diffuse large B-cell lymphoma of the cervico-thoracic junction.

Br J Neurosurg 2020 Oct 5:1-4. Epub 2020 Oct 5.

Neurosurgery Unit, Highly Specialized Hospital and of National Importance "Garibaldi", Catania, Italy.

Background: Diffuse large B-cell lymphoma (DLBCL) in rare cases can presents an unusual expression of CD3 T-cell specific antigen. We report the first case of a CD3-positive DLBCL of the cervico-thoracic junction presenting with persistent cervical radiculopathy.

Case Presentation: A 74-years-old male patient presented a severe and persistent right C8 radiculopathy associated with right-sided neck pain, progressive numbness and weakness of the right arm. Read More

View Article and Full-Text PDF
October 2020

Diagnosis of Hodgkin Lymphoma from Cell Block: A Reliable and Helpful Tool in "Selected" Diagnostic Practice.

Diagnostics (Basel) 2020 Sep 25;10(10). Epub 2020 Sep 25.

Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.

Background: The diagnosis of lymphoma requires surgical specimens to perform morphological evaluation, immunohistochemical and molecular analyses. Ultrasound-guided fine needle aspiration may represent an appropriate first approach to obtain cytological samples in impalpable lesions and/or in patients unsuitable for surgical procedures. Although cytology has intrinsic limitations, the cell block method may increase the possibility of achieving an accurate diagnosis. Read More

View Article and Full-Text PDF
September 2020

Nontraumatic chylothorax secondary to lymphoma and filariasis.

J Surg Case Rep 2020 Sep 21;2020(9):rjaa309. Epub 2020 Sep 21.

Thoracic Surgery, Hospital Centro Médico, Guatemala City, Guatemala.

Chylothorax is characterized by extravasation of chyle into the pleural space resulting from thoracic duct damage. The effusion is most commonly unilateral, with the right and left side being affected in 50% and 33.3% of the patients, respectively. Read More

View Article and Full-Text PDF
September 2020

Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy.

Am J Trop Med Hyg 2020 11;103(5):1983-1985

Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

COVID-19 has now spread globally, and 10-20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. Read More

View Article and Full-Text PDF
November 2020

Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.

Radiother Oncol 2020 12 3;153:155-162. Epub 2020 Sep 3.

Nuffield Department of Population Health, University of Oxford, Oxford, UK; Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Background And Purpose: Radiation-related heart disease (RRHD) can occur many decades after thoracic radiotherapy for Hodgkin lymphoma (HL) or childhood cancer (CC). To quantify the likely risk of RRHD for patients treated today, dose-response relationships derived from patients treated in previous decades are used. Publications presenting these dose-response relationships usually include estimates of uncertainties in the risks but ignore the effect of uncertainties in the reconstructed cardiac doses. Read More

View Article and Full-Text PDF
December 2020

Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration.

Int J Radiat Oncol Biol Phys 2021 Jan 28;109(1):220-230. Epub 2020 Aug 28.

Department of Radiation Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.

Purpose: Despite high response rates, there has been reluctance to use radiation therapy for patients with relapsed/refractory (r/r) Hodgkin (HL) or aggressive non-Hodgkin lymphoma (NHL) given concerns for subacute and late toxicities. Symptomatic pneumonitis, a subacute toxicity, has an incidence of 17% to 24% (≥grade 2) even with intensity modulated radiation therapy. Proton therapy (PT), which has no exit radiation dose, is associated with a lower dose to lung compared with other radiation techniques. Read More

View Article and Full-Text PDF
January 2021

A Vexing Recurrent Pericardial Effusion Without Underlying Pathology - Subsequent Diagnosis Of Lymphoma Proves A Rare First Presentation.

J Ayub Med Coll Abbottabad 2020 Jul- Sep;32(3):408-409

Nevill Hall Hospital, Abergavenny, Aneurin Bevan University Health Board, United Kingdomd.

An elderly man had recurrent admissions with large symptomatic pericardial effusions. Initial computed tomography (CT) of thorax, abdomen and pelvis and pericardial fluid analysis did not reveal underlying cause. On subsequent presentation, pericardial window was formed but repeat pericardial fluid analysis and biopsy failed to give a diagnosis again. Read More

View Article and Full-Text PDF
December 2020

Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord.

Mult Scler Relat Disord 2020 Oct 5;45:102443. Epub 2020 Aug 5.

Dept. of Radiation Oncology, Ordensklinikum Linz, Linz, Austria.

Background: Radiation has been discussed as a potential causative factor for Multiple Sclerosis (MS). However, it is unresolved whether radiation increases the aggressiveness of the immune system or whether it alters the nervous tissue to become vulnerable to a pre-existing autoimmune attackdisposition. We report a patient with an MS-like disease confined to the irradiated part of his central nervous system (CNS). Read More

View Article and Full-Text PDF
October 2020

Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation.

Radiother Oncol 2020 09 5;150:268-274. Epub 2020 Aug 5.

University of Groningen, University Medical Centre Groningen, Department of Radiation Oncology, Groningen, The Netherlands.

Purpose: Pencil beam scanned proton therapy (PBS-PT) treatment quality might be compromised by interplay and motion effects. Via fraction-wise reconstruction of 4D dose distributions and dose accumulation, we assess the clinical relevance of motion related target dose degradation in thoracic cancer patients.

Methods And Materials: For the ten thoracic patients (Hodgkin lymphoma and non-small cell lung cancer) treated at our proton therapy facility, daily breathing pattern records, treatment delivery log-files and weekly repeated 4DCTs were collected. Read More

View Article and Full-Text PDF
September 2020

Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation.

Pediatr Blood Cancer 2020 09 16;67(9):e28429. Epub 2020 Jul 16.

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.

Extracorporeal membrane oxygenation (ECMO) may be used in extreme circumstances for patients with a mediastinal mass and respiratory failure. We report on a young man with primary mediastinal B-cell lymphoma invading into the trachea, requiring a 40-day ECMO run who underwent fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and treatment with concurrent mediastinal irradiation and continuous infusion chemotherapy while on this life-saving technology. This case illustrates that oncology patients may be managed by multidisciplinary teams for extended periods in extraordinary circumstances using multimodality therapies. Read More

View Article and Full-Text PDF
September 2020

A case report of primary adrenal lymphoma: A rare but aggressive and invasive disease.

Medicine (Baltimore) 2020 Jul;99(28):e20938

Department of Endocrinology and Metabolism, Adrenal Center.

Rationale: Primary adrenal lymphoma (PAL) is an extremely rare and highly invasive malignant disease. Imaging examination usually shows bilateral adrenal involvement with large tumor masses and local infiltration. However, it is unclear how lymphoma dynamically develops into huge tumor masses in the adrenal glands. Read More

View Article and Full-Text PDF

Convex probe endobronchial ultrasound guided transbronchial/transoesophageal fine needle aspiration (C-EBUS-TBNA/EUS-B FNA) of pleural lesions: A single center experience and review of literature.

Monaldi Arch Chest Dis 2020 Jul 10;90(3). Epub 2020 Jul 10.

Anatomopathologist, AAS5 Friuli Occidentale, Pordenone.

The evaluation of pleural diseases has been well established. If pleurocentensis is non-diagnostic, the second investigation depending upon availability could be either closed pleural biopsy or image guided pleural biopsy or thoracoscopic pleural biopsy (medical or surgical). Pleural disease presenting as thickness/mass/nodule in the mediastinum is difficult to access through ultrasound or computed tomography and will need thoracoscopy. Read More

View Article and Full-Text PDF

Primary pulmonary extranodal natural killer/T-cell lymphoma (ENKTL), nasal type: Two case reports and literature review.

Medicine (Baltimore) 2020 Jun;99(26):e20822

Department of Cardio-Thoracic Surgery, Shenzhen University General Hospital.

Introduction: Extranodal natural killer/T-cell lymphoma (ENKTL) - nasal type is an aggressive form of malignant non-Hodgkin lymphoma with a very poor prognosis. Especially primary pulmonary ENKTL is a relatively rare form of non-Hodgkin lymphoma. Until now, the prevalence of primary pulmonary ENKTL is unknown. Read More

View Article and Full-Text PDF

[Circular resection of the thoracic trachea for MALT lymphoma in an 81-year-old patient].

Khirurgiia (Mosk) 2020 (5):96-99

Tomsk Regional Clinical Hospital, Tomsk, Russia.

A rare clinical observation of primary tracheal MALT lymphoma is reported and difficulties of differential diagnosis are discussed. Tracheal neoplasms are rare tumors and characterized by delayed diagnosis after clinical manifestation (tracheal stenosis and associated complications). These tumors often occur an advanced age patients that complicates examination and surgical treatment. Read More

View Article and Full-Text PDF

[Thymoma Presenting Synchronously with a Mycosis Fungoides;Report of a Case].

Kyobu Geka 2020 Jun;73(6):466-470

Department of Thoracic Surgery, Kanazawa Medical Center, Kanazawa, Japan.

A 65-year-old woman presented with mycosis fungoides and an anterior mediastinal tumor. Stage Ⅱa mycosis fungoides was treated with bath psoralen plus ultraviolet A, topical corticosteroids, and oral bexarotene. One month later, a surgical resection was performed for the anterior mediastinal tumor, which was a stage Ⅱ thymoma with membrane invasion. Read More

View Article and Full-Text PDF

Primary bone lymphoma of the thoracic vertebra in a patient with metastatic lung cancer.

Clin Imaging 2020 Aug 20;64:119-123. Epub 2020 Apr 20.

Department of Radiology, Liuzhou Worker's Hospital, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China. Electronic address:

We present a rare case of primary diffuse large B-cell lymphoma of the thoracic vertebra in a patient with metastatic lung cancer. Read More

View Article and Full-Text PDF

Vanishing Bone Metastases in 18F-FDG PET/CT.

Clin Nucl Med 2020 Jul;45(7):559-560

Service de Radiologie, Centre Hospitalier Universitaire de Reims, Reims, France.

A 36-year-old woman with a history of large B-cell lymphoma was referred for the exploration of sclerotic bone thoracic vertebral metastases discovered on a contrast-enhanced CT examination. F-FDG PET showed no pathological uptake in the affected vertebrae, as well as normal vertebral density on the coupled unenhanced CT. After review of the initial contrast-enhanced CT, a left brachiocephalic vein stenosis was noted, leading to a retrograde contrast filling of the accessory hemiazygos vein and the capillary spaces within the vertebrae, mimicking sclerotic metastases. Read More

View Article and Full-Text PDF

Burkitt's lymphoma of the prostate presenting as acute urinary retention: a case report.

BMC Urol 2020 May 6;20(1):53. Epub 2020 May 6.

Department of Urology and Pediatric Urology, University Hospital, Philipps-University Marburg, Baldingerstr. 1, 35043, Marburg, Germany.

Background: Non-Hodgkin lymphomas, which include Burkitt's lymphoma, affect the prostate in only 0.1% of cases. They most commonly present as painless lymphadenopathy elsewhere in the body and can cause abdominal or thoracic pain and systemic symptoms such as fever, weight loss and night sweats. Read More

View Article and Full-Text PDF

Primary Diffuse Large B-Cell Non-Hodgkin's Lymphoma of the Thoracic Spine Presented Initially as an Epigastric Pain.

Asian J Neurosurg 2020 Jan-Mar;15(1):162-164. Epub 2020 Feb 25.

Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Non-Hodgkin's lymphoma (NHL) compromises the vast majority of lymphomas and predominantly takes on the form of B-cell lymphomas. More specifically, 30% of all newly diagnosed cases of NHL in the United States (US) are of diffuse large B-cell lymphoma (DLBCL) type, making it the most prevalent form of NHL in the US. Arising from either nodal or extra-nodal lymphatic tissue origin, DLBCL is an aggressive tumor which is fatal if left untreated. Read More

View Article and Full-Text PDF
February 2020